PI4K

PI4K inhibitors block phosphatidylinositol 4-kinases (PI4Ks), which make a key Golgi membrane lipid. Their product, phosphatidylinositol 4-phosphate (PI4P), marks Golgi and plasma membranes and is the precursor of phosphatidylinositol 4,5-bisphosphate. Mammalian cells have four PI4Ks, the type II enzymes PI4KIIα and PI4KIIβ and the type III enzymes PI4KIIIα and PI4KIIIβ. Many positive-strand RNA viruses, including enteroviruses, recruit PI4KIIIβ to build their replication membranes. PI4KIIIbeta-IN-10 and T-00127_HEV1 inhibit this isoform, while PIK-93 also acts on several phosphoinositide 3-kinases (PI3Ks). In 2013, Plasmodium PI4K was identified as the target of antimalarial imidazopyrazines such as KDU691. MMV390048 and UCT943 also inhibit the parasite enzyme and are used in malaria parasite models.

Items 26-28 of 28

  • NC03
    Cat. No.
    A79906

    NC03

    NC03 is a selective inhibitor of PI4K2A, a key enzyme involved in phosphatidylinositol 4-phosphate (PI4P) synthesis. By disrupting the activity of PI4K2A, NC03 effectively reduces PI4P levels within cellular compartments, particularly in the Golgi and Rab7-positive late endosomes. This reagent is valuable for studies exploring lipid signaling, membrane trafficking, and cellular processes influenced by PI4P dynamics.

    1 mg
    $85.00
    5 mg
    $215.00
    All 6 sizes
  • PI4KIIIbeta-IN-11
    Cat. No.
    A79907

    PI4KIIIbeta-IN-11

    PI4KIIIbeta-IN-11 is a potent inhibitor of the enzyme PI4KIIIβ, exhibiting a mean pIC50 value of at least 9.1. This compound is instrumental in studying the biological mechanisms associated with RNA viruses and Plasmodium falciparum, making it valuable for research related to infectious diseases and potential therapeutic targets. Its ability to selectively inhibit PI4KIIIβ highlights its significance in advancing our understanding of these complex disease pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI4KIII beta inhibitor 5
    Cat. No.
    A79908

    PI4KIII beta inhibitor 5

    PI4KIII beta inhibitor 5 is a selective inhibitor of PI4KIIIβ with an IC50 of 19 nM. This compound effectively induces apoptosis and causes cell cycle arrest at the G2/M phase, while also promoting autophagy through the inhibition of the PI3K/AKT signaling pathway. Notably, PI4KIII beta inhibitor 5 exhibits significant antitumor activity in the H446 xenograft model of small cell lung cancer, making it a valuable tool for research in cancer therapy.

    Out of stock

    All 3 sizes

Items 26-28 of 28

Added to your cart

View Cart Checkout

    Loading...